| REVIEWS |
|
|
|
|
|
Naturally Occurring Terpenes: A Promising Class of Organic Molecules to Address Influenza Pandemics |
| Suhad A. A. Al-Salihi1, Fabrizio Alberti2 |
1 Applied Sciences Department, University of Technology, Baghdad, Iraq;
2 School of Life Sciences and Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, UK |
|
|
|
|
Abstract Since the olden times, infectious diseases have largely affected human existence. The newly emerged infections are excessively caused by viruses that are largely associated with mammal reservoirs. The casualties of these emergencies are significantly influenced by the way human beings interact with the reservoirs, especially the animal ones. In our review we will consider the evolutionary and the ecological scales of such infections and their consequences on the public health, with a focus on the pathogenic influenza A virus. The nutraceutical properties of fungal and plant terpene-like molecules will be linked to their ability to lessen the symptoms of viral infections and shed light on their potential use in the development of new drugs. New challenging methods in antiviral discovery will also be discussed in this review. The authors believe that pharmacognosy is the “wave of future pharmaceuticals”, as it can be continually produced and scaled up under eco-friendly requirements. Further diagnostic methods and strategies however are required to standardise those naturally occurring resources.
|
| Keywords
Influenza A
Virus
Fungal terpenes
Plant terpenes
Antivirals
|
|
Corresponding Authors:
Suhad A. A. Al-Salihi, Fabrizio Alberti
E-mail: Suhad.A.Ahmed@uotechnology.edu.iq;f.alberti@warwick.ac.uk
|
|
Issue Date: 30 July 2021
|
|
|
1. A. Mack, E.R. Choffnes, M.A. Hamburg, D.A. Relman (eds.), Microbial Evolution and Co-Adaptation:A Tribute to the Life and Scientific Legacies of Joshua Lederberg:Workshop Summary (National Academies Press, Washington DC, 2009)
2. R.M. Anderson, B. Anderson, R.M. May, Infectious Diseases of Humans:Dynamics and Control (Oxford University Press, Oxford, 1992).
3. C.C. Sreenivasan, M. Thomas, R.S. Kaushik, D. Wang, F. Li, Influenza A in bovine species:a narrative literature review. Viruses 11(6), 561 (2019)
4. M.K. Parvez, S. Parveen, Evolution and emergence of pathogenic viruses:past, present, and future. Intervirology 60(1-2), 1-7 (2017)
5. F. Krammer, G.J. Smith, R.A. Fouchier, M. Peiris, K. Kedzierska, P.C. Doherty, P. Palese, M.L. Shaw, J. Treanor, R.G. Webster, A. García-Sastre, Influenza (primer). Nat. Rev. 4, 3 (2018)
6. U. Lindequist, T.H. Niedermeyer, W.D. Jülich, The pharmacological potential of mushrooms. Evid. Based Complement. Altern. Med. 2(3), 285-299 (2005)
7. S. Santibañez, A.E. Fiore, T.L. Merlin, S. Redd, A primer on strategies for prevention and control of seasonal and pandemic influenza. Am. J. Public Health 99(S2), S216-S224 (2009)
8. M. Sahoo, L. Jena, S.N. Rath, S. Kumar, Identification of suitable natural inhibitor against influenza A (H1N1) neuraminidase protein by molecular docking. Genomics Inform. 14(3), 96 (2016)
9. S. Caini, G. Kusznierz, V.V. Garate, S. Wangchuk, B. Thapa, F.J. de Paula Jr, W.A.F. de Almeida, R. Njouom, R.A. Fasce, P. Bustos, L. Feng, Z. Peng, J.L. Araya, A. Bruno, D. de Mora, M.J.B. de Gámez, R. Pebody, M. Zambon, R. Higueros, R. Rivera, H. Kosasih, M.R. Castrucci, A. Bella, H.A. Kadjo, C. Daouda, A. Makusheva, O. Bessonova, S.S. Chaves, G.O. Emukule, J.M. Heraud, N.H. Razanajatovo, A. Barakat, F. El Falaki, A. Meijer, G.A. Donker, Q.S. Huang, T. Wood, A. Balmaseda, R. Palekar, B.M. Arévalo, A.P. Rodrigues, R. Guiomar, V.J.M. Lee, L.W. Ang, C. Cohen, F. Treurnicht, A. Mironenko, O. Holubka, J. Bresee, L. Brammer, M.T.Q. Le, P.V.M. Hoang, C. El GuercheSéblain, J. Paget, The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century. PLoS ONE 14(9), e0222381 (2019)
10. A.A. Kelvin, M. Zambon, Influenza imprinting in childhood and the influence on vaccine response later in life. Eurosurveillance 24(48), 1900720 (2019)
11. J.N. Hays, Epidemics and Pandemics:Their Impacts on Human History (Abc-clio, Santa Barbara, 2005).
12. M.E. Francis, M.L. King, A.A. Kelvin, Back to the future for influenza preimmunity-looking back at influenza virus history to infer the outcome of future infections. Viruses 11(2), 122 (2019)
13. W.J. Shieh, Advanced pathology techniques for detecting emerging infectious disease pathogens, in Advanced Techniques in Diagnostic Microbiology. ed. by Y.W. Tang, C. Stratton (Springer, Cham, 2018), pp. 543-561
14. L.P.C. Shek, B.W. Lee, Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatr. Respir. Rev. 4(2), 105-111 (2003)
15. C.B. Hall, R.G. Douglas, Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics 55(5), 673-677 (1975)
16. B. Mänz, M. Schwemmle, L. Brunotte, Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. J. Virol. 87(13), 7200-7209 (2013)
17. A.J. Hay, V. Gregory, A.R. Douglas, Y.P. Lin, The evolution of human influenza viruses. Philos. Trans. R. Soc. London Ser. B 356(1416), 1861-1870 (2001)
18. K. Hancock, V. Veguilla, X. Lu, W. Zhong, E.N. Butler, H. Sun, F. Liu, L. Dong, J.R. DeVos, P.M. Gargiullo, T.L. Brammer, N.J. Cox, T.M. Tumpey, J.M. Katz, Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361(20), 1945-1952 (2009)
19. A. Iwasaki, P.S. Pillai, Innate immunity to influenza virus infection. Nat. Rev. Immunol. 14(5), 315-328 (2014)
20. K.M. Gostic, M. Ambrose, M. Worobey, J.O. Lloyd-Smith, Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science 354(6313), 722-726 (2016)
21. W.J. Shieh, D.M. Blau, A.M. Denison, M. Deleon-Carnes, P. Adem, J. Bhatnagar, J. Sumner, L. Liu, M. Patel, B. Batten, P. Greer, T. Jones, C. Smith, J. Bartlett, J. Montague, E. White, D. Rollin, R. Gao, C. Seales, H. Jost, M. Metcalfe, C.S. Goldsmith, C. Humphrey, A. Schmitz, C. Drew, C. Paddock, T.M. Uyeki, S.R. Zaki, 2009 pandemic influenza A (H1N1):pathology and pathogenesis of 100 fatal cases in the United States. Am. J. Pathol. 177(1), 166-175 (2010)
22. R. Linnakoski, D. Reshamwala, P. Veteli, M. Cortina-Escribano, H. Vanhanen, V. Marjomäki, Antiviral agents from fungi:diversity, mechanisms and potential applications. Front. Microbiol. 9, 2325 (2018)
23. J.W. Gnann Jr., N.H. Barton, R.J. Whitley, Acyclovir:mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy 3(5), 275-283 (1983)
24. T. Matthews, R. Boehme, Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10(Supplemnet_3), S490-S494 (1988)
25. J. Junichi Sasaki, Y. Shiino, Y. Kato, D. Kudo, M. Fujita, I. Miyairi, T. Mochizuki, H. Okuda, T. Nagato, Y. Nabetani, T. Takahashi, Checklist for infection control in the emergency department. Acute Med. Surg. 7(1), e540 (2020)
26. R. Li, C. Yang, Q. Du, X. Zhao, H. Jiang, W. Hu, Z. Yang, Pinanamine is a promising lead compound against influenza a virus:evidence from in vitro and in vivo efficacy compared to amantadine. Biol. Pharm. Bull. 40(7), 954-959 (2017)
27. X. Zhao, R. Li, Y. Zhou, M. Xiao, C. Ma, Z. Yang, S. Zeng, Q. Du, C. Yang, H. Jiang, Y. Hu, K. Wang, C.K. Pun-Mok, P. Sun, J. Dong, W. Cui, J. Wang, Y. Tu, Z. Yang, W. Hu, Discovery of highly potent pinanamine-based inhibitors against amantadine-and oseltamivir-resistant influenza A viruses. J. Med. Chem. 61(12), 5187-5198 (2018)
28. A. Schueffler, T. Anke, Fungal natural products in research and development. Nat. Prod. Rep. 31(10), 1425-1448 (2014)
29. S.B. Singh, H. Jayasuriya, R. Dewey, J.D. Polishook, A.W. Dombrowski, D.L. Zink, Z. Guan, J. Collado, G. Platas, F. Pelaez, P.J. Felock, D.J. Hazuda, Isolation, structure, and HIV-1-integrase inhibitory activity of structurally diverse fungal metabolites. J. Ind. Microbiol. Biotechnol. 30(12), 721-731 (2003)
30. W. Fang, X. Lin, X. Zhou, J. Wan, X. Lu, B. Yang, W. Ai, J. Lin, T. Zhang, Z. Tuc, Y. Liu, Cytotoxic and antiviral nitrobenzoyl sesquiterpenoids from the marine-derived fungus Aspergillus ochraceus Jcma1F17. MedChemComm 5(6), 701-705 (2014)
31. D. Hazuda, C.U. Blau, P. Felock, J. Hastings, B. Pramanik, A. Wolfe, F. Bushman, C. Farnet, M. Goetz, M. Williams, K. Silverman, R. Lingham, S. Singh, Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites. Antiviral Chem. Chemother. 10(2), 63-70 (1999)
32. S.B. Singh, D.L. Zink, A.W. Dombrowski, J.D. Polishook, J.G. Ondeyka, J. Hirshfield, P. Felock, D.J. Hazuda, Integracides:tetracyclic triterpenoid inhibitors of HIV-1 integrase produced by Fusarium sp. Bioorg. Med. Chem. 11(7), 1577-1582 (2003)
33. T. Bunyapaiboonsri, S. Yoiprommarat, P. Srikitikulchai, K. Srichomthong, S. Lumyong, Oblongolides from the endophytic fungus Phomopsis sp. BCC 9789. J. Nat. Prod. 73(1), 55-59 (2010)
34. S. Sawadjoon, P. Kittakoop, M. Isaka, K. Kirtikara, S. Madla, Y. Thebtaranonth, Antiviral and antiplasmodial spirodihydrobenzofuran terpenes from the fungus Stachybotrys nephrospora. Planta Med. 70(11), 1085-1087 (2004)
35. J. Yoshimoto, M. Kakui, H. Iwasaki, T. Fujiwara, H. Sugimoto, N. Hattori, Identification of a novel HA conformational change inhibitor of human influenza virus. Adv. Virol. 144(5), 865-878 (1999)
36. K. Minagawa, S. Kouzukim, J. Yoshimoto, Y. Kawamura, H. Tani, T. Iwata, Y. Terui, H. Nakai, S. Yagi, N. Hattori, T. Fujiwara, T. Kamigauchi, Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp. RF-7260. J. Antibiot. 55(2), 155-164 (2002)
37. V.K. Lehmann, A. Huang, S. Ibanez-Calero, G.R. Wilson, K.L. Rinehart, S. Illudin, The sole antiviral compound in mature fruiting bodies of omphalotus illudens. J. Nat. Prod. 66(9), 1257-1258 (2003)
38. Y.C. Zhu, G. Wang, X.L. Yang, D.Q. Luo, Q.C. Zhu, T. Peng, J.K. Liu, Agrocybone, a novel bis-sesquiterpene with a spirodienone structure from basidiomycete Agrocybe salicacola. Tetrahedron Lett. 51(26), 3443-3445 (2010)
39. W. Zhang, J. Tao, X. Yang, Z. Yang, L. Zhang, H. Liu, K. Wu, J. Wu, Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem. Biophys. Res. Commun. 449(3), 307-312 (2014)
40. K. Iwatsuki, T. Akihisa, H. Tokuda, M. Ukiya, M. Oshikubo, Y. Kimura, T. Asano, A. Nomura, H. Nishino, Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. J. Nat. Prod. 66(12), 1582-1585 (2003)
41. B.S. Min, N. Nakamura, H. Miyashiro, K.W. Bae, M. Hattori, Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull. 46(10), 1607-1612 (1998)
42. R.S. El Dine, A.M. El Halawany, C.M. Ma, M. Hattori, AntiHIV-1 protease activity of lanostane triterpenes from the vietnamese mushroom Ganoderma colossum. J. Nat. Prod. 71(6), 1022-1026 (2008)
43. R.A.A. Mothana, N.A. Ali, R. Jansen, U. Wegner, R. Mentel, U. Lindequist, Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia 74(1-2), 177-180 (2003)
44. T.H.J. Niedermeyer, U. Lindequist, R. Mentel, D. Gördes, E. Schmidt, K. Thurow, M. Lalk, Antiviral terpenoid constituents of Ganoderma pfeifferi. J. Nat. Prod. 68(12), 1728-1731 (2005)
45. F. Alberti, S. Kaleem, J.A. Weaver, Recent developments of tools for genome and metabolome studies in basidiomycete fungi and their application to natural product research. Biol. Open 9, bio056010 (2020)
46. S. Bergmann, J. Schümann, K. Scherlach, C. Lange, A.A. Brakhage, C. Hertweck, Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat. Chem. Biol. 3(4), 213-217 (2007)
47. N. Khaldi, F.T. Seifuddin, G. Turner, D. Haft, W.C. Nierman, K.H. Wolfe, N.D. Fedorova, SMURF:genomic mapping of fungal secondary metabolite clusters. Fungal Genet. Biol. 47(9), 736-741 (2010)
48. A.A. Brakhage, Regulation of fungal secondary metabolism. Nat. Rev. Microbiol. 11(1), 21-32 (2013)
49. K.D. Clevenger, J.W. Bok, R. Ye, G.P. Miley, M.H. Verdan, T. Velk, C. Chen, K. Yang, M.T. Robey, P. Gao, M. Lamprecht, P.M. Thomas, M.N. Islam, J.M. Palmer, C.C. Wu, N.P. Keller, N.L. Kelleher, A scalable platform to identify fungal secondary metabolites and their gene clusters. Nat. Chem. Biol. 13(8), 895 (2017)
50. D.L. Hawksworth, R. Lücking, Fungal diversity revisited:2.2 to 3.8 million species. Fungal Kingd. (2017). https://doi.org/10.1128/microbiolspec.FUNK-0052-2016
51. S. Chen, J. Xu, C. Liu, Y. Zhu, D.R. Nelson, S. Zhou, C. Li, L. Wang, X. Guo, Y. Sun, H. Luo, Y. Li, J. Song, B. Henrissat, A. Levasseur, J. Qian, J. Li, X. Luo, L. Shi, L. He, L. Xiang, X. Xu, Y. Niu, Q. Li, M.V. Han, H. Yan, J. Zhang, H. Chen, A. Lv, Z. Wang, M. Liu, C.D. Schwartz, C. Sun, Genome sequence of the model medicinal mushroom Ganoderma lucidum. Nat. Commun. 3, 913 (2012)
52. V.P. Rincão, K.A. Yamamoto, N.M.P.S. Ricardo, S.A. Soares, L.D.P. Meirelles, C. Nozawa, R.E.C. Linhares, Polysaccharide and extracts from Lentinula edodes:structural features and antiviral activity. Virol. J. 9, 37 (2012)
53. K. Bloch, S. Chaykin, A.H. Phillips, A. De Waard, Mevalonic acid pyrophosphate and isopentenylpyrophosphate. J. Biol. Chem. 234(10), 2595-2604 (1959)
54. P.P. Brahmkshatriya, P.S. Brahmkshatriya, Terpenes:chemistry, biological role, and therapeutic applications. Nat. Prod. 12, 2665-2691 (2013)
55. R. Patel, R. Garg, S. Erande, G.B. Maru, Chemopreventive herbal anti-oxidants:current status and future perspectives. J. Clin. Biochem. Nutr. 40(2), 82-91 (2007)
56. J.P. Dai, X.F. Zhao, J. Zeng, Q.Y. Wan, J.C. Yang, W.Z. Li, X.X. Chen, G.F. Wang, K.S. Li, Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity. PLoS ONE 8(4), e61026 (2013)
57. S. Vimalanathan, J. Hudson, Anti-influenza virus activity of essential oils and vapors. Am. J. Essential Oils Nat. Prod. 2(1), 47-53 (2014)
58. Q. Liao, Z. Qian, R. Liu, L. An, X. Chen, Germacrone inhibits early stages of influenza virus infection. Antiviral Res. 100, 578-588 (2013)
59. W.N. Setzer, Essential oils as complementary and alternative medicines for the treatment of influenza. Am. J. Essential Oils Nat. Prod. 4(4), 16-22 (2016)
60. H. Kiyohara, C. Ichino, Y. Kawamura, T. Nagai, N. Sato, H. Yamada, Patchouli alcohol:in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth. J. Nat. Med. 66, 55-61 (2012)
61. Y.C. Li, S.Z. Peng, H.M. Chen, F.X. Zhang, P.P. Xu, J.H. Xie, J.J. He, J.N. Chen, X.P. Lai, Z.R. Su, Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice. Int. Immunopharmacol. 12, 294-301 (2011)
62. H. Wu, B. Li, X. Wang, M. Jin, G. Wang, Inhibitory effect and possible mechanisms of action of patchouli alcohol against influenza A (H3N2) virus. J. Ethnopharmacol. 16, 6489-6501 (2011)
63. M. Paulpandi, S. Kannan, R. Thangam, K. Kaveri, P. Gunasekaran, C. Rejeeth, In vitro anti-viral effect of β-santalol against viral replication. Phytomedicine 19, 231-235 (2012)
64. S. Van Vuuren, S. de Rapper, Odoriferous therapy:identifying the antimicrobial potential of essential oils against pathogens of the respiratory tract. Chem. Biodivers. 17, e2000062 (2020)
65. A. Garozzo, R. Timpanaro, B. Bisignano, P.M. Furneri, G. Bisignano, A. Castro, In vitro antiviral activity of Melaleuca alternifolia essential oil. Lett. Appl. Microbiol. 49, 806-808 (2009)
66. A. Garozzo, R. Timpanaro, A. Stivala, G. Bisignano, A. Castro, Activity of Melaleuca alternifolia (tea tree) oil on Influenza virus A/PR/8:study on the mechanism of action. Antiviral Res. 89, 83-88 (2011)
67. R. Saller, J. Reichling, M. Rostock, F. Iten, J. Melzer, Gastrointestinal symptoms in people with tumours-phytotherapeutic treatment options. Swiss J. Holistic Med./Swiss J. Integr. Med. 20(4), 221-230 (2008)
68. A. Salminen, M. Lehtonen, T. Suuronen, K. Kaarniranta, J. Huuskonen, Terpenoids:natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential. Cell. Mol. Life Sci. 65(19), 2979-2999 (2008)
69. T.V. Teplyakova, T.A. Kosogova, Antiviral effect of agaricomycetes mushrooms. Int. J. Med. Mushrooms 18(5), 375-386 (2016)
70. R. Kiyama, Estrogenic terpenes and terpenoids:pathways, functions and applications. Eur. J. Pharmacol. 815, 405-415 (2017)
71. R. Paduch, M. Trytek, S.K. Król, J. Kud, M. Frant, M. KandeferSzerszeń, J. Fiedurek, Biological activity of terpene compounds produced by biotechnological methods. Pharm. Biol. 54(6), 1096-1107 (2016)
72. C.Y. Wang, Y.W. Chen, C.Y. Hou, Antioxidant and antibacterial activity of seven predominant terpenoids. Int. J. Food Prop. 22(1), 230-238 (2019)
73. D. Baker, U. Mocek, C. Garr, Natural products vs. combinatorials:a case study. Spec. Publ. R. Soc. Chem. 257, 66-74 (2000)
74. D.A. van Bergeijk, B.R. Terlouw, M.H. Medema, G.P. van Wezel, Ecology and genomics of actinobacteria:new concepts for natural product discovery. Nat. Rev. Microbiol. 18, 546-558 (2020)
75. R.J. Scheffler, S. Colmer, H. Tynan, A.L. Demain, V.P. Gullo, Antimicrobials, drug discovery, and genome mining. Appl. Microbiol. Biotechnol. 97(3), 969-978 (2013)
76. T.G. Villa, P. Veiga-Crespo (eds.), Antimicrobial Compounds:Current Strategies and New Alternatives (Springer, Berlin, 2013)
77. X. Tang, J. Li, N. Millán-Aguiñaga, J.J. Zhang, E.C. O'Neill, J.A. Ugalde, P.R. Jensen, S.M. Mantovani, B.S. Moore, Identification of thiotetronic acid antibiotic biosynthetic pathways by targetdirected genome mining. ACS Chem. Biol. 10(12), 2841-2849 (2015)
78. B.S. Paulo, R. Sigrist, C.F. Angolini, L.G. De Oliveira, New cyclodepsipeptide derivatives revealed by genome mining and molecular networking. ChemistrySelect 4(27), 7785-7790 (2019)
79. S. Ye, B. Molloy, A.F. Braña, D. Zabala, C. Olano, J. Cortés, F. Morís, J.A. Salas, C. Méndez, Identification by genome mining of a type I polyketide gene cluster from Streptomyces argillaceus involved in the biosynthesis of pyridine and piperidine alkaloids argimycins P. Front. Microbiol. 8, 194 (2017)
80. P.J. Rutledge, G.L. Challis, Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 13(8), 509-523 (2015)
81. A. Craney, C. Ozimok, S.M. Pimentel-Elardo, A. Capretta, J.R. Nodwell, Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Chem. Biol. 19(8), 1020-1027 (2012)
82. C.M. Lazarus, K. Williams, A.M. Bailey, Reconstructing fungal natural product biosynthetic pathways. Nat. Prod. Rep. 31(10), 1339-1347 (2014)
83. N.M. Markina, A.A. Kotlobay, A.S. Tsarkova, Heterologous metabolic pathways:strategies for optimal expression in eukaryotic hosts. Acta Nat. 12(2), 28 (2020) |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
